In this webinar, SVP of Science, Anthony Schmitt, PhD presents on how the 3D genome reveals novel disease mechanisms and therapeutic targets missed by other technologies during the Biomarkers US Conference 2022.
Topics covered:
- How 3D genomic technologies enable scientists to uncover novel disease mechanisms and identify new therapeutic targets.
- How 3D genomics is enabling biomarker discovery, tumor classification, and patient stratification.
- How 3D genomics is revealing genetic drivers of previously undiagnosed tumors, reshaping how we understand disease, and yielding exciting new opportunities in precision oncology.
- Q&A
Негізгі бет A New Frontier in Biomarker Discovery - October 4, 2022
Пікірлер